Sirio Pharma (300791) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.035x

Based on the latest financial reports, Sirio Pharma (300791) has a cash flow conversion efficiency ratio of 0.035x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.61 Million ≈ $14.87 Million USD) by net assets (CN¥2.91 Billion ≈ $425.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sirio Pharma market capitalisation for the company's overall valuation and market capitalisation.

Sirio Pharma - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sirio Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sirio Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sirio Pharma ranked by their cash flow conversion efficiency. Explore cash flow quality index of Sirio Pharma to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Guangdong Vanward New Electric Co Ltd SHE:002543	-0.005x
Shandong New Beiyang Information Technology Co Ltd SHE:002376	-0.004x
Hangzhou Huaguang Advanced Welding Materials Co Ltd SHG:688379	-0.011x
Gujarat Ambuja Exports Limited NSE:GAEL	0.038x
South Plains Financial Inc NASDAQ:SPFI	0.042x
SERVICE STREAM LTD F:UFY	N/A
Guangdong SACA Precision Manufacturing Co Ltd SHE:300464	0.010x
Hangzhou Haoyue Personal Care Co Ltd SHG:605009	0.031x

Annual Cash Flow Conversion Efficiency for Sirio Pharma (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sirio Pharma from 2016 to 2024. View Sirio Pharma stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.64 Billion ≈ $386.49 Million	CN¥566.97 Million ≈ $82.97 Million	0.215x	+42.68%
2023-12-31	CN¥2.57 Billion ≈ $375.51 Million	CN¥386.08 Million ≈ $56.50 Million	0.150x	-8.63%
2022-12-31	CN¥2.70 Billion ≈ $395.32 Million	CN¥444.86 Million ≈ $65.10 Million	0.165x	+22.75%
2021-12-31	CN¥2.54 Billion ≈ $372.38 Million	CN¥341.38 Million ≈ $49.95 Million	0.134x	-8.38%
2020-12-31	CN¥2.18 Billion ≈ $319.40 Million	CN¥319.57 Million ≈ $46.76 Million	0.146x	+22.96%
2019-12-31	CN¥1.95 Billion ≈ $284.62 Million	CN¥231.60 Million ≈ $33.89 Million	0.119x	-49.11%
2018-12-31	CN¥784.05 Million ≈ $114.73 Million	CN¥183.46 Million ≈ $26.85 Million	0.234x	+175.08%
2017-12-31	CN¥580.20 Million ≈ $84.90 Million	CN¥49.35 Million ≈ $7.22 Million	0.085x	+140.25%
2016-12-31	CN¥464.98 Million ≈ $68.04 Million	CN¥-98.26 Million ≈ $-14.38 Million	-0.211x	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$777.99 Million

CN¥5.32 Billion CNY

Market Cap Rank

#10104 Global

#2679 in China

Share Price

CN¥17.30

Change (1 day)

+1.17%

52-Week Range

CN¥15.63 - CN¥25.86

All Time High

CN¥57.47